Attention-Deficit/Hyperactivity Disorder as a Risk Factor for COVID-19 Infection.
J Atten Disord
; 26(7): 985-990, 2022 May.
Article
in English
| MEDLINE | ID: covidwho-1477171
ABSTRACT
OBJECTIVE:
To postulate that ADHD is a potential risk factor for COVID-19 infection; to evaluate the COVID-19 risk factor on drug-treated ADHD subjects.METHODS:
A retrospective chart review was performed on ADHD subjects aged 6 to 18 years in Israel, who had undergone at least one COVID-19 test during the study period.RESULTS:
Of the 64,409 subjects included in the study, 6,207 (9.64%) had at least one positive COVID-19 test result, 13,300 (20.65%) were diagnosed with ADHD, and of whom 1,751 (13%) had purchased at least two ADHD medications 3 months prior to COVID-19 testing and were defined as being medically treated. Medically-treated ADHD subjects had a significantly lower likelihood to be infected with COVID-19 than untreated subjects.CONCLUSION:
Untreated ADHD patients seem to constitute a risk group for COVID-19 infection. Drug treatment ameliorates risk of spreading COVID-19 infection within the pediatric population and secondary spread in the general population.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Attention Deficit Disorder with Hyperactivity
/
COVID-19
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Adolescent
/
Child
/
Humans
Language:
English
Journal:
J Atten Disord
Journal subject:
Psychology
/
Psychiatry
Year:
2022
Document Type:
Article
Affiliation country:
10870547211044217
Similar
MEDLINE
...
LILACS
LIS